<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Alcohol</journal-id><journal-id journal-id-type="iso-abbrev">Alcohol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Alcohol (Fayetteville, N.Y.)</journal-title></journal-title-group><issn pub-type="ppub">0741-8329</issn><issn pub-type="epub">1873-6823</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11405091</article-id><article-id pub-id-type="pmcid-ver">PMC11405091.1</article-id><article-id pub-id-type="pmcaid">11405091</article-id><article-id pub-id-type="pmcaiid">11405091</article-id><article-id pub-id-type="manuscript-id">NIHMS2018531</article-id><article-id pub-id-type="pmid">38908609</article-id><article-id pub-id-type="doi">10.1016/j.alcohol.2024.06.006</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2018531</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2018531</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Risk of mortality among patients with alcohol-associated hepatitis in the US from 2007 to 2021</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Tu</surname><given-names initials="W">Wanzhu</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liangpunsakul</surname><given-names initials="S">Suthat</given-names></name><degrees>MD, MPH</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nguyen</surname><given-names initials="CM">Chi Mai</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Healey</surname><given-names initials="R">Ryan</given-names></name><degrees>MS</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Y">Yang</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Radaeva</surname><given-names initials="S">Svetlana</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gawrieh</surname><given-names initials="S">Samer</given-names></name><degrees>MD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bataller</surname><given-names initials="R">Ramon</given-names></name><degrees>MD</degrees><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Su</surname><given-names initials="J">Jing</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Biostatistics &amp; Health Data, Indiana University School of Medicine, Indianapolis, IN 46202</aff><aff id="A2"><label>2</label>Regenstrief Institute, Inc., Indianapolis, IN 46202</aff><aff id="A3"><label>3</label>Roudebush Veterans Administration Medical Center, Indianapolis, IN 46202</aff><aff id="A4"><label>4</label>Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202</aff><aff id="A5"><label>5</label>National Institute of Alcohol Abuse and Alcoholism, Bethesda, MD</aff><aff id="A6"><label>6</label>Universitat de Barcelona, Spain</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">Contributed equally to this work</p></fn><fn fn-type="con" id="FN2"><p id="P2">Authorship contributions:
<list list-type="bullet" id="L2"><list-item><p id="P3">Conceptualization: WT, SL, and JS</p></list-item><list-item><p id="P4">Data collection and preparation: JS, CMN, RH, and WT</p></list-item><list-item><p id="P5">Statistical methodology and data analysis: CMN, RH, YL, JS, and WT</p></list-item><list-item><p id="P6">Visualization: JS, RH, and CMN,</p></list-item><list-item><p id="P7">Data interpretation: JS, SL, SG, and WT</p></list-item><list-item><p id="P8">Writing: WT</p></list-item><list-item><p id="P9">Critical revision: WT, SL, SR, RB, SG, and JS</p></list-item><list-item><p id="P10">Funding acquisition: WT, SG, and SL</p></list-item></list></p></fn><corresp id="CR1"><bold>Correspondence</bold>: Suthat Liangpunsakul, MD, 702 Rotary Circle, Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, <email>sliangpu@iu.edu</email></corresp><fn fn-type="COI-statement" id="FN3"><p id="P40"><bold>Conflict of interest statement</bold>: Dr. Gawrieh is a consultant to TransMedics, Pfizer. He received research grant support from Viking, Sonic Incytes, and Zydus. None of the other authors had conflicts of interest to disclose.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>20</day><month>6</month><year>2024</year></pub-date><volume>120</volume><issue-id pub-id-type="pmc-issue-id">470807</issue-id><fpage>143</fpage><lpage>150</lpage><pub-history><event event-type="nihms-submitted"><date><day>11</day><month>09</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-17 17:25:29.180"><day>17</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2018531.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background/Aims:</title><p id="P11">Alcohol-associated hepatitis (AH) mortality and risk factors have not been carefully studied in real-world settings. We examined the rate, temporal trend, and risk factors of mortality in AH.</p></sec><sec id="S2"><title>Methods:</title><p id="P12">We conducted a cohort study of individuals with AH diagnoses using medical claims data from Optum&#8217;s Clinformatics<sup>&#174;</sup> Data Mart (CDM). Participants were individuals covered by Medicare Advantage and commercial insurance policies. Cases were identified using diagnostic codes. Cox regressions were used to estimate 90 and 180-day mortality rates by hospitalization status.</p></sec><sec id="S3"><title>Results:</title><p id="P13">The cohort included 32,001 patients (72% men) who had at least one year of continuous insurance coverage prior to AH diagnoses. Of these, 20,912 were hospitalized within seven days of diagnosis. Ninety and 180-day mortality rates were 12.0% (95% CI [11.6%, 12.5%]) and 16.0% (95% CI [15.4%, 16.5%]), respectively, for the hospitalized patients and 3.1% (95% CI [2.8%, 3.4%]) and 5.1% (95% CI [4.6%, 5.5%]) for the non-hospitalized patients. Pre-existing liver disease, even in a mild form, was associated with an increased risk of death. In hospitalized patients, a history of mild liver disease was associated with a 24% increase in 180-day mortality risk (HR= 1.24, 95% CI: [1.14, 1.36]). Moderate-to-severe liver disease was associated with a more than doubled risk (HR= 2.33, 95% CI: [2.12, 2.56]).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P14">History of liver disease was associated with significantly increased AH mortality. The finding highlights the chronic disease context of AH and suggests that prior diagnosis of liver disease should be considered for prognosis and targeted prevention.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>